A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections
一种新型的DNA促旋酶B抑制剂是治疗结核病和非结核分枝杆菌感染的有效候选药物。
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.1
doi:10.1128/AAC.04347-14.
Christopher P Locher,Steven M Jones,Brian L Hanzelka,Emanuele Perola,Carolyn M Shoen,Michael H Cynamon,Andile H Ngwane,Ian J Wiid,Paul D van Helden,Fabrice Betoudji,Eric L Nuermberger,John A Thomson
